Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on the Safety and Tolerability of ST-920 Gene Therapy for Patients with Fabry Disease
GermanyStudy on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp
FranceStudy on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis
BulgariaStudy on Bimekizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis
BelgiumStudy on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults
AustriaStudy of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy
GreeceStudy on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis
BelgiumStudy on the Effectiveness and Safety of Ruxolitinib Cream for Adults with Chronic Hand Eczema
GermanyStudy on the Effects of Ruxolitinib Cream for Patients with Genital Vitiligo
FranceStudy of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
BelgiumStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
AustriaStudy on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus
FranceThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
